A rating of 86 puts Castle Biosciences Inc (CSTL) near the top of the Diagnostics & Research industry according to InvestorsObserver. Castle Biosciences Inc's score of 86 means it scores higher than 86% of stocks in the industry. Castle Biosciences Inc also received an overall rating of 65, putting it above 65% of all stocks. Diagnostics & Research is ranked 33 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Castle Biosciences Inc Stock Today?
Castle Biosciences Inc (CSTL) stock is trading at $66.12 as of 3:13 PM on Wednesday, Dec 16, a gain of $5.06, or 8.29% from the previous closing price of $61.06. Volume today is high. So far 2,172,472 shares have traded compared to average volume of 242,687 shares. The stock has traded between $59.18 and $69.74 so far today.
Click Here to get the full Stock Score Report on Castle Biosciences Inc (CSTL) Stock.
